FAQ: How Do You Explain Remission To A Patient?
Description
Thank you AbbVie for your support on this FAQ Video Module.
In this GHAPP FAQ Video Module, Christie Morrison, from Oshi Health and Texas Digestive Disease Consultants, explains how to discuss clinical remission with patients living with inflammatory bowel disease (IBD), including both Crohn’s disease and ulcerative colitis. She breaks down the different types of remission—clinical, biochemical, endoscopic, and steroid-free—and offers clear, practical ways for APPs and healthcare providers to communicate these concepts during patient visits. Christie discusses how to use objective markers such as CRP, ESR, fecal calprotectin, and lactoferrin, and how endoscopic scoring tools like the SES-CD and Mayo score can help track improvement and long-term disease control. She also emphasizes setting realistic expectations, the importance of treat-to-target goals, and the ultimate aim of achieving deep remission while minimizing steroid use. Watch to gain actionable strategies to educate your IBD patients about their treatment journey and the steps toward sustained remission.
#IBD #CrohnsDisease #UlcerativeColitis #ClinicalRemission #GHAPP #IBDTreatment #APPeducation #TreatToTarget #IBDManagement
United States
